Tsuruoka, Japan · Founded 2020 · Privately Held (backing)
Operator of microbiome therapeutics and manufacturing platform intended to advance precision treatment using fecal microbiota transplantation. Metagen Therapeutics is based in Tsuruoka, Japan and was founded in 2020. Its last reported valuation was $54.2 million in Jan 2026. It has raised $36.5 million.
Last reported valuation
$54.2M
Oct 2026
Priced at
—
Total raised
$36.5M
Last round
—
Cap table — not yet on record
Metagen Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Metagen Therapeutics with a free account
·The complete investor list: 27 names
·Watch Metagen Therapeutics: the Monday email on marks, rounds and moves
